90
Views
83
CrossRef citations to date
0
Altmetric
Research Article

Oesophageal cancer incidence and mortality in patients with long-segment Barrett's Oesophagus after a mean follow-up of 12.7 years

, , , , &
Pages 1175-1179 | Published online: 08 Jul 2009

References

  • Spechler SJ. Clinical practice. Barrett’s Esophagus. N Engl J Med 2002;346:836–42.
  • Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am 1997;26:487–94.
  • Hameeteman W, Tytgat GN, Houthoff HJ, van den Tweel JG. Barrett’s esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989;96:1249–56.
  • Van der Burgh A, Dees J, Hop WCJ, van Blankenstein M. Oesophageal cancer is an uncommon cause of death in patients with Barrett’s oesophagus. Gut 1996;39:5–8.
  • Haggitt RC. Barrett’s esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994;25:982–93.
  • Montgomery E, Bronner MP, Goldblum JR, Greenson JK, Haber MM, Hart J, et al. Reproducibility of the diagnosis of dysplasia in Barrett’s esophagus: a reaffirmation. Hum Pathol 2001;32:368–78.
  • Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287–9.
  • Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and the esophagogastric junction. Gastroenterology 1993;104: 510–3.
  • Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049–53.
  • Farrow DC, Vaughan TL. Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States). Cancer Causes Control 1996;7:322–7.
  • Dulai GS. Surveying the case for surveillance. Gastroenterology 2002;122:820–3.
  • Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett’s) esophagus: Comparison of population-based clinical and autopsy findings. Gastroenterology 1990;99:918–22.
  • Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett’s esophagus in asymptomatic individuals. Gastroenterology 2002;123:461–7.
  • Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus. Am J Gastroenterol 2002;97:1888–95.
  • Katz D, Rothstein R, Schned A, Dunn J, Seaver K, Antonioli D. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett’s esophagus. Am J Gastroenterol 1998;93:536–41.
  • Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett’s esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997;92: 212–5.
  • Macdonald CE, Wicks AC, Playford RJ. Final results from a 10- year cohort of patients undergoing surveillance for Barrett’s oesophagus: observational study. Br Med J 2000;321: 1252–5.
  • Reid BJ, Haggitt RC, Rubin CE. Observer variation in the diagnosis of dysplasia in Barrett’s esophagus. Hum Pathol 1988; 19:166–78.
  • Skacel M, Petras RE, Gramlich TL, Gramlich TL, Richter JE, Falk GW, et al. The diagnosis of low-grade dysplasia in Barrett’s esophagus and its implications for disease progression. Am J Gastroenterol. 2000;95:3383–7.
  • Montgomery E, Goldblum JR, Greenson JK, Haber MM, Lamps LW, Lauwers GY, et al. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. Hum Pathol 2001;32:379–88.
  • Weston AP, Badr AS, Hassanein RS. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett’s multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol. 1999;94:3413–9.
  • Menke-Pluymers MBE, Hop WCJ, Dees J, van Blankenstein M, Tilanus HW. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. Cancer 1993;72: 1155–8.
  • Iftikhar SY, James PD, Steele RJC, Hardcastle JD, Atkinson M. Length of Barrett’s esophagus: An important factor in the development of dysplasia and adenocarcinoma. Gut 1992;33:1155–8.
  • Corley DA, Levin TR, Habel L, Weiss NS, Buffler PA. Association between surveillance and survival in Barrett’s adenocarcinoma: a population-based study. Gastroenterology 2002; 122: 633–40.
  • Cooper GS, Yuan Z, Chak A, Rimm AA. Association of prediagnosis endoscopy with stage and survival in adenocarcinoma of the esophagus and gastric cardia. Cancer 2002;95:32–8.
  • Kearney DJ, Crump C, Maynard C, Boyko EJ. A case control study of endoscopy and mortality from adenocarcinoma of the esophagus or gastric cardia in persons with gastroesophageal reflux disease. Gastrointest Endosc 2003;57:823–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.